Zoetis

Zoetis develops and manufactures animal-health medicines and vaccines whose customers include veterinarians, pet owners, and livestock farmers.
Sipa via AP Images

Company Information

As of 10/10/2022
Country
U.S.
Headquarters
Parsippany, N.J.
Industry
Pharmaceuticals
CEO
Kristin Peck
Company Type
Public
Ticker
ZTS
Revenues ($M)
$7,776
Profits ($M)
$2,035
Market Value ($M)
$69,420
Employees
12,100
Market value as of Sept. 30, 2022.

Change the World

Impact Segment
Environmental Impact/Economic Opportunity
Sector
Health Care
Prior Year Rank
-

Key Financials (Last Fiscal Year)

$ millions
% change
Revenues ($M)
-
-
Profits ($M)
-
-
Assets ($M)
-
-
Total Stockholder Equity ($M)
-
-

Profit Ratios

Profit as % of Revenues
-
Profits as % of Assets
-
Profits as % of Stockholder Equity
-

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)
-
EPS % Change (from 2020)
-
EPS % Change (5 year annual rate)
-
EPS % Change (10 year annual rate)
-

Total Return

Total Return to Investors (2021)
-
Total Return to Investors (5 year, annualized)
-
Total Return to Investors (10 year, annualized)
-
Lists ranking Zoetis
RANK440
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MORE
RANK20
Change the World - 2022...READ MORE